Chromogranin A in pituitary adenomas: Immunohistochemical detection and plasma concentrations

Folia Histochemica et Cytobiologica

Volumn 42, Issue 4, 2004, Pages 245-247

  Pawlikowski, Marek ^a   Gruszka, Anna ^a   Radek, Maciej ^a   Kunert Radek, Jolanta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Chromogranin A; Gonadotropinomas; Null cell adenomas; Pituitary tumors

Indexed keywords

CHROMOGRANIN A; GONADOTROPIN; HYPOPHYSIS HORMONE;

ARTICLE; BRAIN SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NULL CELL; PREOPERATIVE EVALUATION; PROLACTINOMA; PROTEIN BLOOD LEVEL;

EID: 8344241959     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Colombo P, Siccardi AG, Paganelli G, Magnani P, Songini C, Buffa R, Faglia G, Fazio F (1996) Three step immunoscintigraphy with anti-chromogranin A monoclonal antibody in tumours of the pituitary region. Eur J Endocrinol 135: 216-221
2. Ferrari L, Seregni E, Bajetta E, Marinetti A, Bombardieri E (1999) The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours. Anticancer Res 19: 3415-3428
3. Gussi IL, Young J, Baudin E, Bidart JM,Chanson P (2003) Chromogranin A as serum marker of pituitary adenomas. Clin Endocrinol 59: 644-648
4. Jin L, Zhang S, Bayliss J, Scheithauer B, Qian X, Kobayashi I, Stridsberg M, Lloyd RV (2003) Chromogranin A processing in human pituitary adenomas and carcinomas: analysis with region specific antibodies. Endocr Pathol 14: 37-48
5. Kimura N, Miura W, Noshiro T, Mizunashi K, Hanew K, Shimizu K, Watanabe T, Shibukawa S, Sohn HE, Abe K, Miura Y, Nagura H (1997) Plasma chromogranin A in pheochromocytoma, primary hyperparathyroidism and pituitary adenoma in comparison with catecholamine, parathyroid hormone and pituitary hormones. Endocr J 44: 319-327
6. Kimura N, Sasano N, Yamada R, Satoh J (1988) Immunohistochemical study of chromogranin in 100 cases of pheochromocytoma, carotid body tumour, medullary thyroid carcinoma and carcinoid tumour. Virch Arch A 413: 33-38
7. Lamberts SW, Hofland LJ, Nobels FR (2001) Neuroendocrine tumor markers. Front Neuroendocrinol 22: 309-339
8. Lloyd RV, Scheithauer BW, Kovacs K, Roche PC (1996) The immunophenotype of pituitary adenomas. Endocr Pathol 7: 145-150
9. Nehar D, Deschamps M, Andrelli F, Claustrat B, Sassolas G (1999) Immunoradiometric assay of chromogranin A in patients with neuroendocrine tumors and pituitary adenomas. 9th Meeting of the European Neuroendocrine Association, Odense, September 3-7, 1999, Programme & Abstracts, Abstr 8-12
10. Nehar D, Lombard-Bohas C, Olivieri S, Claustrat B, Chayvialle JA, Penes MC, Sassolas G, Borson-Chazot F (2004) Interest of chromogranin A for diagnosis and follow-up of endocrine tumours. Clin Endocrinol 60: 644-52
11. Pawlikowski M (1997) The significance of the immunocytochemical investigations in diagnosis and prognosis of pituitary adenomas. Folia Histochem Cytobiol 35: 109-110
12. Pawlikowski M, Kunert-Radek J, Radek A (2000) Gonadotropinoma - a frequent subtype of pituitary adenoma. Endokrynol Pol 51: 77-81
13. Talan-Hranilovic J, Gnjidic Z, Sajko T, Vizner B, Vrkljan M (2000) Comparative immunohistochemical analysis of estrogen receptor and chromogranin A reactivity in plurihormonal human prolactinomas. Acta Med Croatica 54: 59-63
14. Trouillas J, Girod C, Sassolas G, Claustrat B, Perrin G (1990) La cellule gonadotrope humaine normale et tumorale. Ann Endocrinol 51: 54-64